Want to join the conversation?
$AGN along with $PRGO announced yesterday that $AGN received FDA approval for three Mucinex equivalent products; MucinexÂ® DM Regular Strength, MucinexÂ® DM Maximum Strength & MucinexÂ® Maximum Strength. By 2016 cold & cough season, these products will be shipped to US by $PRGO.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.